Zydus Life launches trivalent influenza vaccine 'VaxiFlu' in India
This story was originally published at 13:35 IST on 2 September 2025
Register to read our real-time news.Informist, Tuesday, Sept. 2, 2025
--Zydus Life launches trivalent influenza vaccine 'VaxiFlu' in India
MUMBAI – Zydus Lifesciences Ltd. Tuesday said it has launched trivalent influenza vaccine, VaxiFlu, for the first time in India. It is used to treat flu, which is a significant global health concern of seasonal influenza annually, the company said in an exchange filing.
The company reported a consolidated net profit of INR 14.67 billion for the June quarter on revenue of INR 65.74 billion. At 1325 IST, shares of the company traded 1% higher at INR 999.95 on the National Stock Exchange. End
IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT
Reported by Simran Rede
Edited by Subhojit Sarkar
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2025. All rights reserved.
To read more please subscribe
Share this Story:
